Superoxide Dismutase 1 Nanoparticles (Nano-SOD1) as a Potential Drug for the Treatment of Inflammatory Eye Diseases

Superoxide Dismutase 1 Nanoparticles (Nano-SOD1) as a Potential Drug for the Treatment of Inflammatory Eye Diseases

Inflammatory eye diseases remain the most common clinical problem in ophthalmology. The secondary processes associated with inflammation, such as overproduction of reactive oxygen species (ROS) and exhaustion of the endogenous antioxidant system, frequently lead to tissue degeneration, vision blurri...

Full description

Bibliographic Details
Main Authors: Alexander N. Vaneev, Olga A. Kost, Nikolay L. Eremeev, Olga V. Beznos, Anna V. Alova, Peter V. Gorelkin, Alexander S. Erofeev, Natalia B. Chesnokova, Alexander V. Kabanov, Natalia L. Klyachko
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Biomedicines
Subjects:
nanoparticles
Nano-SOD1
inflammation
uveitis
eye diseases
double-layered polyelectrolyte complex
Online Access:https://www.mdpi.com/2227-9059/9/4/396

Internet

https://www.mdpi.com/2227-9059/9/4/396

Similar Items